Helen Sabzevari, PhD, President and CEO, Precigen, to provide a company presentation on Wednesday, October 11 at 3:30 PM PT at the Cell & Gene Meeting on the Mesa conference taking place from October 10 to 12 in Carlsbad, California.

Dr. Scott M. Norberg, Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, will present an abstract titled, "Significant clinical benefit and enhanced T-cell responses with repeated administration of PRGN-2012, a novel gorilla adenoviral vector based immunotherapy, in adult patients with severe Recurrent Respiratory Papillomatosis.

Helen Sabzevari, PhD, President and CEO, Precigen, to participate in an Acute Myeloid Leukemia (AML) panel discussion on Thursday, October 26 at 2:00 PM ET.